Daily Recap: Business — 9 July 2026

Business news today captures an economy still being reshaped by supply constraints, strategic investment and stubborn costs. In pharma, Dr. Reddy’s has delayed semaglutide supplies after finding an active ingredient quality issue, a setback that is expected to push it short of annual targets even as the company says patient safety is unaffected. In chips, Micron won investor approval with plans to invest up to $3 billion to deepen the U.S. semiconductor supply chain, underscoring how manufacturers are racing to secure capacity amid strong memory demand. India is making a similar infrastructure play, with Gujarat unveiling an ambitious data-centre policy aimed at attracting ₹6 lakh crore and 7.5 gigawatts of capacity. Meanwhile, the U.S. housing market remains painfully unaffordable as record home prices collide with higher mortgage rates and weaker sales. And in Europe, Hugo Boss is telling shareholders to reject Frasers’ takeover approach as too low.

Top Business stories

• Gujarat launches Data Centre Policy 2026–29 targeting ₹6 lakh crore investment and 7.5 GW capacity (6 sources)
• Micron to invest up to $3 billion to expand U.S. semiconductor supply chain (6 sources)
• Hugo Boss Board Urges Shareholders to Reject Frasers’ Takeover Offer (5 sources)
• U.S. home prices reach record high as existing home sales slow and mortgage rates rise (5 sources)
• Goldman Sachs bans employees from most prediction market trading tied to finance and politics (4 sources)
• Goldman warns Hormuz tensions could delay Middle East oil supply recovery (4 sources)
• 5.5-Magnitude Earthquake Strikes Czech Republic and Slovakia, GFZ Reports (4 sources)
• Dr Reddy’s shares fall on semaglutide batch quality issue and supply delays (4 sources)

Read the full daily recap on NewSumm →